Paquinimod

Paquinimod has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jan 26, 2026: “Calprotectin Is a Circulating Biomarker and Potential Therapeutic Target for Sarcopenia in Chronic Obstructive Pulmonary Disease”.

Intervention

1 paper studies it2 findingsUpdated

PubChem

See all 1 papers on paquinimod

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Fundamental Research Funds for the Central Universities and 2 more
  • Animals1

What did studies of paquinimod find?

2

Studies of paquinimod measured 2 outcomes: ubiquitin–proteasome system and grip strength.

Ubiquitin–proteasome system

downin mice1

1 study
  1. Paquinimod inhibits ubiquitin–proteasome system in cigarette smoke-exposed mice.

    “Paquinimod inhibited ubiquitin-proteasome system activity, reduced protein degradation marker levels, attenuated oxidative stress and increased antioxidant enzyme levels in CS-exposed mice.”

    Animalsin cigarette smoke-exposed miceskeletal muscle

    Calprotectin Is a Circulating Biomarker and Potential Therapeutic Target for Sarcopenia in Chronic Obstructive Pulmonary Disease

    Journal of cachexia, sarcopenia and muscle

More on Ubiquitin–proteasome system

Grip strength

upin mice1

1 study
  1. Paquinimod improves grip strength in cigarette smoke-exposed mice (214.9 ± 31.38 g vs. 333.1 ± 34.93 g, p < 0.01).

    “Paquinimod also reduced CS-induced muscle weakness, as indicated by increased grip strength (214.9 ± 31.38 g vs. 333.1 ± 34.93 g; p < 0.01).”

    Animalsin cigarette smoke-exposed mice10 mg/kg/day

    Calprotectin Is a Circulating Biomarker and Potential Therapeutic Target for Sarcopenia in Chronic Obstructive Pulmonary Disease

    Journal of cachexia, sarcopenia and muscle

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months